The Audit Of The Company'S Active Pharmaceutical Ingredients (Api) Manufacturing Plant At Middleburg, New York Has Been Completed By The Us Food And Drug Administration (Usfda), The Hyderabad-Based Drug Major Said In A Regulatory Filing.Dr Reddy'S Laboratories On Wednesday Said The Us Health Regulator Has Issued A Form 483 With Three Observations After Inspecting Its Manufacturing Facility In Middleburg, New York. The Audit Of The Company'S Active Pharmaceutical Ingredients (Api) Manufacturing Plant At Middleburg, New York Has Been Completed By The Us Food And Drug Administration (Usfda), The Hyderabad-Based Drug Major Said In A Regulatory Filing."We Have Been Issued A Form 483 With 3 (Three) Observations. We Will Address Them Comprehensively Within The Stipulated Timeline. Currently, We Do Not Have Any Sales From This Plant," It Added.As Per The Usfda, Form 483 Is Issued To Firm Management At The Conclusion Of An Inspection When Investigators Have Observed Any Conditions That In Their Judgment May Constitute Violations Of The Food Drug And Cosmetic Act And Related Acts. Shares Of The Company On Wednesday Ended 1.15 Per Cent Up At Rs 4,498.65 Apiece On The Bse.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!